經導管心臟瓣膜置換術全球市場規模、佔有率和成長分析：按產品、按手術方法、按最終用途、按應用、按地區 - 行業預測 (2024-2031)

Transcatheter Heart Valve Replacement Market Size, Share, Growth Analysis, By Product, By Surgical Approach, By End-Use, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球經導管心臟瓣膜置換術市場規模估值為58億美元，從2023年的66.7億美元成長到2031年的204億美元，並預計在預測期內成長（2024年-預計複合年成長率為2031 年為 15.0%）。

全球經導管心臟瓣膜置換術(TAVR) 市場正在經歷顯著成長，因為它已成為患有嚴重主動脈瓣疾病的患者首選的傳統心臟直視手術的微創替代方案。這種創新的治療方法允許透過導管插入人工瓣膜，最大限度地減少手術風險、住院時間和恢復時間，使其對高風險或無法手術的患者特別有益。成長的促進因素包括技術進步、患者人數不斷增加以及醫療保健提供者的接受度提高，而老年人口的成長和心血管疾病的激增進一步推動了這一點。持續投資研發旨在改進瓣膜設計和成像技術，以確保改善手術結果。隨著醫療設備製造商和醫療保健相關人員之間合作的加強，TAVR 市場有望持續擴張，顯著改善患者的治療結果和心血管健康。

Edwards Lifesciences Corporation（USA）
Medtronic plc（Ireland）
Boston Scientific Corporation（USA）
Abbott Laboratories（USA）
JenaValve Technology, Inc.（USA）
SYMETIS（Switzerland）
Braile Biomedica（Brazil）
CryoLife, Inc.（USA）
Micro Interventional Devices, Inc.（USA）
LivaNova PLC（UK）
Meril Life Sciences Pvt. Ltd.（India）
Venus Medtech（Hangzhou）Inc.（China）
Suzhou Jiecheng Medical Technology Co. Ltd.（China）
Peijia Medical Limited（China）
Blue Sail Medical Co., Ltd.（China）
Colibri Heart Valve LLC（USA）
HighLife SAS（France）
Neovasc Inc.（Canada）
St. Jude Medical, Inc.（USA）

結論和建議

簡介目錄

Product Code: SQMIG35D2143

Global Transcatheter Heart Valve Replacement Market size was valued at USD 5.8 billion in 2022 and is poised to grow from USD 6.67 billion in 2023 to USD 20.4 billion by 2031, growing at a CAGR of 15.0% during the forecast period (2024-2031).

The global transcatheter heart valve replacement (TAVR) market is experiencing significant growth as it emerges as a preferred minimally invasive alternative to traditional open-heart surgery for patients suffering from severe aortic valve disease. This innovative procedure allows for the implantation of prosthetic valves through catheterization, minimizing surgical risks, hospital stays, and recovery times, making it particularly beneficial for high-risk or inoperable patients. Growth drivers include technological advancements, a larger patient demographic, and increased acceptance among healthcare providers, exacerbated by a growing aging population and a surge in cardiovascular conditions. Ongoing investment in research and development aims to enhance valve designs and imaging techniques, ensuring improved procedural outcomes. As collaborations between medical device manufacturers and healthcare stakeholders strengthen, the TAVR market is poised for sustained expansion, significantly improving patient outcomes and the cardiovascular landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transcatheter Heart Valve Replacement market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transcatheter Heart Valve Replacement Market Segmental Analysis

Global Transcatheter Heart Valve Replacement Market is segmented by product, surgical approach, end-use, application and region. Based on product, the market is segmented into transcatheter pulmonary valve replacement, transcatheter mitral valve repair & replacement and transcatheter aortic valve replacement. Based on surgical approach, the market is segmented into transapical approach, transfemoral approach and others. Based on end-use, the market is segmented into cath labs and hospitals. Based on application, the market is segmented into pulmonary valvular heart disease, mitral valvular heart disease and aortic valvular heart disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transcatheter Heart Valve Replacement Market

The Transcatheter Heart Valve Replacement (THVR) market is significantly influenced by the aging global population and the growing prevalence of heart disease. As individuals age, the incidence of heart valve diseases, particularly conditions like aortic stenosis, is on the rise, which in turn escalates the demand for THVR procedures. With longer life expectancies, more patients are likely to experience valve-related complications, resulting in an expanding market for innovative heart valve replacement solutions. This demographic trend, coupled with the increasing recognition of THVR's benefits over traditional surgical methods, is propelling the market forward, creating opportunities for advancements in medical technology and patient care.

Restraints in the Global Transcatheter Heart Valve Replacement Market

The Global Transcatheter Heart Valve Replacement (THVR) market faces several restraints, notably the high initial costs linked with the procedures. These expenses encompass not only the devices but also the required specialized equipment, making it a significant financial burden. Furthermore, reimbursement issues and inconsistent healthcare policies across various regions can create barriers that limit patient access to these advanced treatments. These financial and policy-related challenges may subsequently impede the overall growth and expansion of the market, as they affect both patient affordability and healthcare provider willingness to adopt THVR solutions in their practices.

Market Trends of the Global Transcatheter Heart Valve Replacement Market

The Global Transcatheter Heart Valve Replacement (THVR) market is experiencing significant growth, fueled by rapid technological advancements and an increasing preference for minimally invasive procedures. Cutting-edge innovations, including enhanced valve designs, state-of-the-art imaging techniques, and novel delivery systems, are revolutionizing the field, making procedures safer and more effective. This trend is not only reducing complications but also broadening the spectrum of patients eligible for treatment. Consequently, more healthcare providers are recognizing THVR as a preferred solution for aortic valve diseases, contributing to its expanded adoption and solidifying its position as a critical component of cardiac care worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Transcatheter Heart Valve Replacement Market Size by Product & CAGR (2024-2031)

Market Overview
Transcatheter Pulmonary Valve Replacement
Transcatheter Mitral Valve Repair & Replacement
Transcatheter Aortic Valve Replacement

Global Transcatheter Heart Valve Replacement Market Size by Surgical Approach & CAGR (2024-2031)

Market Overview
Transapical Approach
Transfemoral Approach
Others

Global Transcatheter Heart Valve Replacement Market Size by End-Use & CAGR (2024-2031)

Market Overview
Cath Labs
Hospitals

Global Transcatheter Heart Valve Replacement Market Size by Application & CAGR (2024-2031)

Market Overview
Pulmonary Valvular Heart Disease
Mitral Valvular Heart Disease
Aortic Valvular Heart Disease

Global Transcatheter Heart Valve Replacement Market Size & CAGR (2024-2031)

North America (Product, Surgical Approach, End-Use, Application)
- US
- Canada
Europe (Product, Surgical Approach, End-Use, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Surgical Approach, End-Use, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Surgical Approach, End-Use, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Surgical Approach, End-Use, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Edwards Lifesciences Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JenaValve Technology, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SYMETIS (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braile Biomedica (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micro Interventional Devices, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Venus Medtech (Hangzhou) Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Suzhou Jiecheng Medical Technology Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Peijia Medical Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Blue Sail Medical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Colibri Heart Valve LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HighLife SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neovasc Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
St. Jude Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments